Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 48Lymphoid 43Plasma cell 26Myeloid 20Sarcoma 19Breast 11Dermatologic 10CNS 10Genitourinary 9Gynecologic 7Classical hematology 6Other solid neoplasm 5Gastrointestinal 4Head & Neck 3Endocrine 3NET 2Thoracic 1Other 1

Conditions

Xerostomia 1Squamous Cell Carcinoma of Head and Neck 1Mucositis 1Head and Neck Neoplasms 1

Interventions

tegaserod 3naloxegol 3Radiotherapy 3Cisplatin 3Surveys and Questionnaires 2Radiation 2Lidocaine 2prucalopride 1pegfilgrastim 1oxycodone naloxone combination 1indole-3-carbinol 1hydrated silica gel-based toothpaste 1glucarpidase 1angiotensin I (1-7) 1alvimopan 1aluminum hydroxide, magnesium hydroxide, drug combination 1Vitamin D 1Transcutaneous Electric Nerve Stimulation 1Thyrotropin-Releasing Hormone 1Tablets 1Surgical Procedures, Operative 1Sennosides 1Selenomethionine 1Phenolphthalein 1Observation 1Nutrition Assessment 1Neck Dissection 1Methotrexate 1Methods 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Filgrastim × Other × Clear all
NCT00352118 2017-12-28

Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
4 enrolled 4 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡